e-Therapeutics proposes £29m fundraising, delisting from AIM
10th Apr 2024 12:32
(Sharecast News) - RNAi medicines data and development specialist e-Therapeutics proposed a fundraise and its delisting from AIM on Wednesday.
Read moreE-Therapeutics enters collaboration with Arcturis Data
2nd Nov 2023 14:32
(Sharecast News) - E-Therapeutics announced a strategic collaboration with Arcturis Data on Thursday - a prominent UK data company known for its high-quality, real-world data platform.
Read moreEight new patent applications filed by e-therapeutics
1st Aug 2022 13:29
(Sharecast News) - Computational drug discovery and development company e-therapeutics announced the filing of eight further patent applications in the United States on Monday, to protect innovation arising from its proprietary 'GalNAc-siRNA' technology.
Read moreE-therapeutics reaches 'key milestone' in Galapagos collaboration
12th Apr 2022 13:26
(Sharecast News) - Drug discovery specialist E-therapeutics announced on Tuesday that it has reached a key milestone in its collaboration with Galapagos.
Read moreE-therapeutics finance chief stepping down due to family
22nd Nov 2021 14:16
(Sharecast News) - Drug discovery company E-therapeutics announced on Monday that Karl Keegan was stepping down from his non-board role as chief financial officer, to focus on "extremely difficult" family circumstances in Ireland.
Read moreeTherapeutics CFO to stand down on 31 December
22nd Nov 2021 10:20
(Sharecast News) - Drug discovery e-Therapeutics revealed on Monday that chief financial officer Karl Keegan will step down from the role in order to focus on "extremely difficult family circumstances" in Ireland.
Read moreE-therapeutics meets 'key milestone' in Galapagos collaboration
2nd Jul 2021 13:47
(Sharecast News) - E-therapeutics has met a key milestone in its collaboration with Galapagos, a commercial-stage company specialising in the discovery and development of small-molecule medicines with novel modes of action, with a focus on inflammation, fibrosis and kidney disease, it announced on Friday.
Read moreE-therapeutics brings in Alison Gallafent as head of IP
2nd Jun 2021 09:42
(Sharecast News) - Drug discovery company e-therapeutics announced the appointment of Alison Gallafent as its head of intellectual property on Wednesday.
Read moreE-therapeutics raises £22.5m to expand capabilities and pipeline
14th May 2021 14:20
(Sharecast News) - E-therapeutics has completed a placing, subscription and retail offer via PrimaryBid, it announced on Friday, conditionally raising gross proceeds of £22.5m to help expand its drug discovery and development capabilities and asset pipeline.
Read moreE-therapeutics to receive two milestone payments from Galapagos
23rd Apr 2021 10:18
(Sharecast News) - E-therapeutics has met two key milestones in its collaboration with small-molecule medicines specialist Galapagos, it announced on Friday.
Read moree-Therapeutics 're-energised' by Mortazavi appointment
12th Oct 2020 10:06
(Sharecast News) - Drug discovery and development company e-Therapeutics said on Monday that it was feeling "re-energised" by the addition of former Silence Therapeutics boss Ali Mortazavi amid active discussions with large pharmaceutical and biotechnology firms regarding potential collaborations.
Read moreE-therapeutics enters collaboration deal with Galapagos
10th Jun 2020 09:20
(Sharecast News) - E-therapeutics has entered a collaboration agreement with Galapagos to identify new therapeutic approaches to modulate a specific mechanism involved in idiopathic pulmonary fibrosis (IPF), and potentially in other fibrotic indications, it announced on Wednesday.
Read moreE-Therapeutics launches research collaboration with Novo Nordisk
10th Dec 2018 14:30
(Sharecast News) - E-Therapeutics announced a research collaboration with Novo Nordisk on Monday, under which the two companies would use e-Therapeutics' proprietary 'Network-Driven Drug Discovery' (NDD) platform to look to discover potentially novel biological mechanisms and therapeutic approaches for a specific area of type-2 diabetes.
Read moreE-Therapeutics and C4X upbeat on Parkinson's collaboration
6th Dec 2018 16:04
(Sharecast News) - Network-driven drug discovery company e-Therapeutics and C4X Discovery Holdings updated the market on their collaboration on Thursday, to identify novel intervention strategies for the potential treatment of Parkinson's Disease (PD).
Read moree-Therapeutics narrows interim losses as it eyes commercial viability
4th Oct 2018 11:08
(Sharecast News) - Half-year losses at e-Therapeutics have narrowed as the drug discovery and development firm continued to manage costs.
Read more